A bill to require the Administrator of the Drug Enforcement Administration to temporarily exempt buprenorphine from the Suspicious Orders Report System for the remainder of the opioid public health emergency.
Read twice and referred to the Committee on the Judiciary.
Email me when S 5783 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 5783. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill directs the DEA Administrator to remove buprenorphine from the Suspicious Orders Report system for the duration of the declared opioid public health emergency. By doing so, it seeks to make it easier for doctors to prescribe the medication that treats opioid use disorder. The change would affect DEA reporting rules and the providers who dispense buprenorphine.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 5783
3 free questions a day, no accountSponsors
- Sen. Heinrich, Martin [D-NM] (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 5783 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 5783 freeOr ask your AI assistant about S 5783 directly:
Add to Claude, ChatGPT or Cursor